Gustavo Mostoslavsky

Summary

Affiliation: Boston University
Country: USA

Publications

  1. ncbi New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer
    David F Stroncek
    Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, USA
    J Transl Med 10:48. 2012
  2. ncbi Shb deficient mice display an augmented TH2 response in peripheral CD4+ T cells
    Karin Gustafsson
    Department of Medical Cell Biology, Uppsala University, Sweden
    BMC Immunol 12:3. 2011
  3. ncbi Concise review: The magic act of generating induced pluripotent stem cells: many rabbits in the hat
    Gustavo Mostoslavsky
    Section of Gastroenterology, Department of Medicine and Center for Regenerative Medicine CReM, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    Stem Cells 30:28-32. 2012
  4. ncbi Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector
    Cesar A Sommer
    Section of Gastroenterology, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    Stem Cells 28:64-74. 2010
  5. ncbi Mouse ES and iPS cells can form similar definitive endoderm despite differences in imprinted genes
    Constantina Christodoulou
    Boston University Pulmonary Center, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    J Clin Invest 121:2313-25. 2011
  6. ncbi Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells
    Sarah Eminli
    Massachusetts General Hospital Cancer Center and Center for Regenerative Medicine, Boston, Massachusetts, USA
    Nat Genet 41:968-76. 2009
  7. ncbi Critical-size calvarial bone defects healing in a mouse model with silk scaffolds and SATB2-modified iPSCs
    Jin Hai Ye
    Division of Oral Biology, Tufts University School of Dental Medicine, One Kneeland Street, Boston, MA 02111, USA
    Biomaterials 32:5065-76. 2011
  8. ncbi Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette
    Aba Somers
    Boston University Pulmonary Center, Boston, Massachusetts 02118, USA
    Stem Cells 28:1728-40. 2010
  9. ncbi Induced pluripotent stem cell generation using a single lentiviral stem cell cassette
    Cesar A Sommer
    Department of Medicine, Boston University School of Medicine, Massachusetts 02118, USA
    Stem Cells 27:543-9. 2009
  10. ncbi Residual expression of reprogramming factors affects the transcriptional program and epigenetic signatures of induced pluripotent stem cells
    Cesar A Sommer
    Section of Gastroenterology, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America
    PLoS ONE 7:e51711. 2012

Collaborators

  • Darrell N Kotton
  • Jin Zhang
  • Konrad Hochedlinger
  • Qisheng Tu
  • Anjana Rao
  • George Daley
  • Lin Wang
  • Daniel J Weiss
  • Jun Zhao
  • Akiko Shimamura
  • Hanno Hock
  • Jun Gao
  • Donald E Ingber
  • David Kaplan
  • Stuart H Orkin
  • Cesar A Sommer
  • Constantina Christodoulou
  • George J Murphy
  • David F Stroncek
  • Avrum Spira
  • Steven S Shen
  • Jin Hai Ye
  • Kian Peng Koh
  • Karin Gustafsson
  • Jake Chen
  • Xuejing Duan
  • Paul Gadue
  • Tyler A Longmire
  • Aba Somers
  • Andreia Gianotti Sommer
  • Akiko Mammoto
  • Sarah Eminli
  • Matthias Stadtfeld
  • Karyn M Austin
  • Hui Pan
  • Luca Gattinoni
  • Nicholas P Restifo
  • Hadas Hezroni
  • Francesco M Marincola
  • Michael Kalos
  • Martin A Cheever
  • Carolina Berger
  • Mark E Dudley
  • Daniel J Powell
  • Andreia Gianotti-Sommer
  • Cornelis J M Melief
  • Eran Meshorer
  • Peter Flynn
  • Richard W Childs
  • John O'Shea
  • Badi Sri Sailaja
  • James R Heath
  • Steven A Rosenberg
  • Mahendra Rao
  • Jeffrey S Miller
  • Vitezslav Kriz
  • Cesar Sommer
  • Scott J Rodig
  • Kjell Olov Grönvik
  • Michael Welsh
  • Birgitta Heyman
  • Julie Nardone
  • Fredrik Hjelm
  • Asta Laiho
  • Akiko Yabuuchi
  • Yuan Jin Xu
  • Mamta Tahiliani
  • Yu nong Wu
  • Alice Bourdon
  • Valerie Gouon-Evans
  • Shi Guo Yan
  • Gabriela Calounova
  • Chen Ping Zhang
  • Xue Jing Duan
  • Kerrianne Cunniff
  • Sridhar Rao
  • Riitta Lahesmaa
  • Yun Huang
  • Jinhai Ye
  • Pishan Yang
  • Marie France Demierre
  • Lei Ying
  • Jenny M Jean
  • Dolly D Thomas
  • Deborah L French
  • Brenden W Smith
  • Christopher C Ford
  • Amel Omari
  • Fred W Alt
  • Jyh Chang Jean

Detail Information

Publications17

  1. ncbi New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer
    David F Stroncek
    Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, USA
    J Transl Med 10:48. 2012
    ..In the future, combinations of adoptive transfer of T cells and specific vaccination against the cognate antigen can be envisaged to further enhance the effectiveness of these therapies...
  2. ncbi Shb deficient mice display an augmented TH2 response in peripheral CD4+ T cells
    Karin Gustafsson
    Department of Medical Cell Biology, Uppsala University, Sweden
    BMC Immunol 12:3. 2011
    ..A Shb knockout mouse was recently generated and the aim of the current study was to address the importance of Shb deficiency on T cell development and function...
  3. ncbi Concise review: The magic act of generating induced pluripotent stem cells: many rabbits in the hat
    Gustavo Mostoslavsky
    Section of Gastroenterology, Department of Medicine and Center for Regenerative Medicine CReM, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    Stem Cells 30:28-32. 2012
    ....
  4. ncbi Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector
    Cesar A Sommer
    Section of Gastroenterology, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    Stem Cells 28:64-74. 2010
    ..In addition, our results underscore the consequences of long-term culture that will need to be taken into account for the clinical application of iPS cells...
  5. ncbi Mouse ES and iPS cells can form similar definitive endoderm despite differences in imprinted genes
    Constantina Christodoulou
    Boston University Pulmonary Center, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    J Clin Invest 121:2313-25. 2011
    ..Our results show that, despite some molecular differences, iPS cells can be efficiently differentiated into DE precursors, reinforcing their potential for development of cell-based therapies for diseased endoderm-derived tissues...
  6. ncbi Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells
    Sarah Eminli
    Massachusetts General Hospital Cancer Center and Center for Regenerative Medicine, Boston, Massachusetts, USA
    Nat Genet 41:968-76. 2009
    ..Moreover, we identify hematopoietic progenitors as an attractive cell type for applications of iPS cell technology in research and therapy...
  7. ncbi Critical-size calvarial bone defects healing in a mouse model with silk scaffolds and SATB2-modified iPSCs
    Jin Hai Ye
    Division of Oral Biology, Tufts University School of Dental Medicine, One Kneeland Street, Boston, MA 02111, USA
    Biomaterials 32:5065-76. 2011
    ..In conclusion, the results demonstrate that SATB2 facilitates the differentiation of iPSCs towards osteoblast-lineage cells by repressing HoxA2 and augmenting the functions of the osteoblast determinants Runx2, BSP and OCN...
  8. ncbi Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette
    Aba Somers
    Boston University Pulmonary Center, Boston, Massachusetts 02118, USA
    Stem Cells 28:1728-40. 2010
    ..Moreover, we demonstrate that human iPSC generated with this approach have the ability to robustly differentiate into definitive endoderm in vitro, the developmental precursor tissue of lung epithelia...
  9. ncbi Induced pluripotent stem cell generation using a single lentiviral stem cell cassette
    Cesar A Sommer
    Department of Medicine, Boston University School of Medicine, Massachusetts 02118, USA
    Stem Cells 27:543-9. 2009
    ..The use of a single lentiviral vector for reprogramming represents a powerful laboratory tool and a significant step toward the application of iPS technology for clinical purposes...
  10. ncbi Residual expression of reprogramming factors affects the transcriptional program and epigenetic signatures of induced pluripotent stem cells
    Cesar A Sommer
    Section of Gastroenterology, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America
    PLoS ONE 7:e51711. 2012
    ..Our findings provide new insights into the reprogramming process and emphasize the importance of generating iPSCs free of any residual transgene expression...
  11. ncbi Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells
    Kian Peng Koh
    Immune Disease Institute and Program in Cellular and Molecular Medicine, Children s Hospital Boston, Boston, MA 02115, USA
    Cell Stem Cell 8:200-13. 2011
    ..Thus, 5hmC is an epigenetic modification associated with the pluripotent state, and Tet1 functions to regulate the lineage differentiation potential of ESCs...
  12. ncbi Application of induced pluripotent stem (iPS) cells in periodontal tissue regeneration
    Xuejing Duan
    Division of Oral Biology, Tufts University School of Dental Medicine, Boston, Massachusetts 02111, USA
    J Cell Physiol 226:150-7. 2011
    ..iPS cells combined with EMD provide a valuable tool for periodontal tissue engineering, by promoting the formation of new cementum, alveolar bone, and normal periodontal ligament...
  13. ncbi The evolving field of induced pluripotency: recent progress and future challenges
    Cesar A Sommer
    Section of Gastroenterology, Department of Medicine and Center for Regenerative Medicine, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    J Cell Physiol 228:267-75. 2013
    ....
  14. ncbi Experimental approaches for the generation of induced pluripotent stem cells
    Cesar A Sommer
    Section of Gastroenterology, Department of Medicine and Center for Regenerative Medicine CReM, Boston University School of Medicine, Boston, MA 02118, USA
    Stem Cell Res Ther 1:26. 2010
    ....
  15. ncbi A mechanosensitive transcriptional mechanism that controls angiogenesis
    Akiko Mammoto
    Vascular Biology Program, Department of Pathology and Surgery, Children s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    Nature 457:1103-8. 2009
    ..This is, to our knowledge, the first known functional cross-antagonism between transcription factors that controls tissue morphogenesis, and that responds to both mechanical and chemical cues...
  16. ncbi Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndrome
    Karyn M Austin
    Department of Pediatric Hematology, Children s Hospital Boston, Boston, Massachusetts, USA
    J Clin Invest 118:1511-8. 2008
    ..Conversely, SDS patient cells were resistant to taxol, a microtubule stabilizing agent. These findings suggest that spindle instability in SDS contributes to bone marrow failure and leukemogenesis...
  17. ncbi Dual-promoter lentiviral system allows inducible expression of noxious proteins in macrophages
    Hui Pan
    Department of Immunology and Infectious Diseases, Harvard School of Public Health, 667 Huntington Avenue, Boston, MA 02115, USA
    J Immunol Methods 329:31-44. 2008
    ..Our method will be especially useful to study immunity-related macrophage proteins in their physiological context during macrophage activation or infection...